Premium
Prodrugs: A Reactive Prodrug Ink Formulation Strategy for Inkjet 3D Printing of Controlled Release Dosage Forms and Implants (Adv. Therap. 6/2020)
Author(s) -
He Yinfeng,
Foralosso Ruggero,
Trindade Gustavo F.,
Ilchev Alexander,
RuizCantu Laura,
Clark Elizabeth A.,
Khaled Shaban,
Hague Richard J. M.,
Tuck Christopher J.,
Rose Felicity R. A. J.,
Mantovani Giuseppe,
Irvine Derek J.,
Roberts Clive J.,
Wildman Ricky D.
Publication year - 2020
Publication title -
advanced therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
0ISSN - 2366-3987
DOI - 10.1002/adtp.202070012
Subject(s) - prodrug , inkwell , inkjet printing , controlled release , nanotechnology , drug , extended release , materials science , 3d printed , drug delivery , pharmacology , chemistry , biomedical engineering , medicine , composite material
In article number 1900187 by Clive J. Roberts, Ricky D. Wildman and co‐workers report an entirely new approach to formulating and controlling drug release from 3D printed systems/implants. This approach allows for hierarchical control over release, by exercising control over composition of a printed system over multiple length scales through molecular to macroscopic.